Nootropic Stack Protocol

Overview

Cognitive enhancement through peptides operates on fundamentally different principles than traditional small-molecule nootropics. While compounds like racetams or modafinil primarily modulate existing neurotransmitter levels or receptor activity, nootropic peptides can influence neurotrophin expression, neuroplasticity, neurogenesis, and long-term synaptic remodeling. The effects tend to be more gradual in onset but potentially more durable, reflecting changes in brain architecture rather than transient neurochemical shifts.

The four peptides in this stack — Semax, Selank, Dihexa, and PE-22-28 — were selected because they act through distinct and complementary mechanisms. Semax primarily modulates BDNF (Brain-Derived Neurotrophic Factor) and dopaminergic/noradrenergic pathways. Selank acts on GABAergic and serotonergic systems. Dihexa operates through the hepatocyte growth factor (HGF)/MET receptor pathway to promote synaptogenesis. PE-22-28 has been studied for its effects on neurogenesis and long-term potentiation.

This protocol is structured for researchers interested in cognitive optimization who have already established baseline experience with at least one nootropic peptide. New researchers should begin with a single compound (see Beginner's First Protocol) before attempting a multi-peptide cognitive stack.

Compounds Involved

Mechanism Complementarity

The strength of this stack lies in the non-overlapping nature of the mechanisms:

Semax increases BDNF expression, which supports neuronal survival, synaptic plasticity, and the growth of new dendritic connections. Its dopaminergic activity enhances motivation, focus, and working memory. Originally developed in Russia for stroke recovery, Semax has accumulated substantial clinical use data for cognitive applications.

Selank provides the anxiolytic counterbalance to Semax's stimulatory profile. By modulating GABA — the brain's primary inhibitory neurotransmitter — Selank reduces anxiety and mental noise without sedation at typical doses. Its serotonergic activity supports mood stability, which is foundational for sustained cognitive performance.

Dihexa operates at a fundamentally different level. Rather than modulating neurotransmitter levels, it promotes the physical formation of new synaptic connections through the HGF/MET receptor system. In preclinical models, Dihexa has demonstrated the ability to enhance spatial learning and memory formation at remarkably low doses.

PE-22-28 is derived from the activity-dependent neuroprotective protein (ADNP) and has been studied in preclinical models for its ability to promote hippocampal neurogenesis and enhance long-term potentiation — the cellular mechanism underlying memory consolidation.

Protocol Structure

Phase 1: Semax Foundation (Weeks 1-2)

Begin with Semax alone to establish baseline nootropic peptide response:

• Semax: 200 mcg intranasal, once in the morning
• Administration: One spray per nostril (split dose) or two sprays in one nostril (depending on spray concentration)
• Timing: Upon waking or mid-morning, before cognitive demands
• Assessment: Track focus duration, motivation, verbal fluency, and any side effects (irritability, headache, nasal irritation)

After 7-10 days of confirmed tolerance, increase to 300-600 mcg if desired, or proceed to Phase 2 at the starting dose.

Phase 2: Add Selank (Weeks 3-4)

• Semax: Continue at established dose, morning
• Selank: 200 mcg intranasal, morning (may be administered sequentially with Semax, using alternate nostrils)
• Allow 5-10 minutes between Semax and Selank administration to ensure each is absorbed before the next is applied
• Assessment: Note changes in anxiety levels, mental clarity, and the quality (not just quantity) of focused work

The Semax + Selank pairing is the most established nootropic peptide combination in the community, with years of anecdotal data supporting the complementary stimulatory/anxiolytic balance.

Phase 3: Add Dihexa (Weeks 5-8)

Dihexa is introduced after the Semax/Selank foundation is established:

• Dihexa: Start at the lower end of the dose range (oral or SubQ, depending on formulation)
• Frequency: Once daily
• Timing: Morning, with or after the intranasal peptides
• Assessment: Dihexa's effects on synaptogenesis are expected to develop gradually over weeks rather than days. Look for improvements in learning speed, memory formation, and the ability to make novel connections between concepts

Important: Dihexa has substantially less human use data than Semax or Selank. Conservative dosing and careful monitoring are essential. Some researchers choose to use Dihexa in shorter cycles (4-6 weeks) with extended off periods.

Phase 4: Add PE-22-28 (Weeks 7-12, overlapping with Dihexa)

• PE-22-28: 50-100 mcg intranasal or SubQ, once daily
• Timing: Morning or early afternoon
• Assessment: PE-22-28's neurogenic effects are among the most gradual in this stack. Assess over weeks 8-12 for improvements in memory consolidation, learning retention, and overall cognitive resilience

Full Stack Summary

Cycling Strategy

The full four-compound stack should not be run indefinitely. After a 10-12 week cycle:

• Taper Dihexa and PE-22-28 by reducing to every-other-day dosing for one week, then discontinue
• Continue Semax + Selank for 1-2 additional weeks if desired, then discontinue
• Washout: 4-6 weeks with no nootropic peptides
• During washout: Assess which cognitive improvements persist independently. This information guides the next cycle's compound selection

See Rotation Strategy for long-term cycling frameworks.

Important Considerations

Start with Semax or Selank alone. The full four-compound stack is for experienced nootropic peptide users. If you have never used a nootropic peptide, complete a full single-compound cycle first. The Beginner's First Protocol framework applies to cognitive compounds as well.

Nasal administration technique affects absorption. For intranasal peptides, clear the nasal passages before administration. Tilt the head slightly forward, not back. Spray toward the lateral nasal wall (away from the septum). Avoid sniffing forcefully, which drives the peptide past the nasal mucosa and into the throat. Allow 5 minutes before lying down, blowing your nose, or administering a second compound.

Dihexa requires extra caution. As a potent activator of the HGF/MET pathway, Dihexa has a mechanism profile that warrants respect. The HGF/MET system is involved in cell proliferation and migration — processes that are beneficial for synaptogenesis but carry theoretical concerns in other contexts. Researchers with a personal or family history of certain cell proliferation conditions should discuss this mechanism with a healthcare provider before use.

Cognitive assessment is inherently subjective. Unlike IGF-1 levels for GH secretagogues, there is no simple blood test that measures cognitive enhancement. Use structured assessment tools: timed cognitive tasks (dual n-back, reaction time tests), productivity metrics (focused work hours per day), and consistent subjective rating scales. See Research Documentation Protocol for logging approaches.

Sleep, exercise, and nutrition are foundational. No nootropic peptide stack can compensate for sleep deprivation, sedentary behavior, or poor nutrition. The brain consumes approximately 20% of the body's energy at rest. Adequate glucose delivery, omega-3 fatty acid availability, and quality sleep are prerequisites for any cognitive protocol to reach its potential. See Combining Peptides with Lifestyle.

Monitor for overstimulation. The combination of Semax's dopaminergic activity with Dihexa and PE-22-28 can, in some individuals, produce overstimulation symptoms: irritability, insomnia, racing thoughts, or difficulty disengaging from tasks. If these occur, reduce Semax dose first, then reassess. Selank's anxiolytic properties partially offset this risk, which is one reason it is included in the stack.

Blood work considerations. While nootropic peptides are not primarily hormonal, a baseline and follow-up thyroid panel (TSH, free T3, free T4) is recommended, as some neurotrophic compounds can influence thyroid axis activity. Cortisol levels are also worth monitoring given the stress-modulatory effects of Selank. See Blood Work Monitoring.

Disclaimer

This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Peptides discussed here are research compounds and may not be approved for human use in all jurisdictions. Several compounds in this protocol (particularly Dihexa and PE-22-28) have limited human safety data. Always consult a qualified healthcare provider before beginning any new protocol, especially one involving compounds that affect brain function. Individual responses vary, and the information presented here reflects preclinical and anecdotal data rather than established clinical guidelines.